Spine surgery company Accelus set for $482M SPAC merger

Accelus announced that it entered into a definitive business combination agreement with CHP Merger Corp. worth approximately $482 million.

Upon the closing of the agreement — expected for early 2022 — CHP Merger Corp., a special purpose acquisition company (SPAC), will be renamed Accelus. Accelus CEO & Co-Founder Chris Walsh, formerly of Stryker and NuVasive, will become the CEO of the combined company.

According to a news release, CHP Chairman Joseph Swedish, formerly of Anthem, Trinity Health, Centura and HCA Healthcare, and Alex Lukianov, who previously worked at NuVasive, BackCare Group, Smith+Nephew and Medtronic, will join the newly combined company’s board of directors.

Palm Beach Gardens, Florida-based Accelus, a commercial-stage medtech company aiming to accelerate the adoption of minimally invasive surgery as the standard of care in the spinal space, has a portfolio of spinal implants using its Adaptive Geometry Technology and a compa…

Read more
  • 0